High intensity focused ultrasound (HIFU) for prostate cancer
(PCa)
The diagnosis
More and more men suffer from prostate cancer
(carcinoma of the prostate, prostate cancer). A cancerous growth
is frequently discovered during an examination by a specialist or
when treating a benign increase in the size of the prostate. A final
determination regarding the diagnosis of cancer is obtained by means
of the PSA level, additional diagnostics and, if required, taking
tissue samples (biopsy).
Lately it has also been possible to detect cancerous growth in the
subclinical phase by isolating, counting and molecularly characterizing
circulating tumor cells. You can find more information about this
on the page => Biopsy-free
diagnostics. An analysis of the proteomes in the urine (DiaPat)
can verify an important indicator for prostate cancer. MR spectroscopy
makes it possible to see the cancerous areas.
It is possible to achieve touchless sealing of the tumor with HIFU
therapy so that a spreading of the tumor cells is avoided. As a
rule, unlike with radical surgery, incontinence or impotence do
not occur.
The US company Focus
Surgery from Indianapolis, Indiana developed, in cooperation
with the urologist Dr. Joachim-Ernst Deuster from Heidelberg, Germany,
the Sonablate 500, a device that works with intense and bundled
ultrasound in accordance with the HIFU (High Intensity Focused Ultrasound)
principle. The Sonablate 500 is produced at Misonix
Inc. in Farmingdale, New York.
A comprehensive consultation
regarding possible risks is conducted before every treatment.
Treatment
The patient is initially given a mild
general anesthetic, which is combined with local anesthesia near
the prostate. This type of anesthesia was specifically developed
for this by a renowned anesthesiologist from the Clinic for Prostate
Therapy in Heidelberg for the HIFU procedure. The patient is in
a kind of deep sleep and does not have to deal with the consequences
of full anesthesia.
The treatment itself is carried out in the lithotomy position
(dorsal position) with legs slightly bent so that the treatment
probe can be inserted through the rectum and introduced into the
prostate. In most cases, this approach presents no problems whatsoever.
The HIFU principle
A transducer head is inserted into the
rectum. It has two functions. It creates an ultrasound picture
of the prostate on the one hand, while on the other it captures
and calculates the area that must be irradiated. To be on the
safe side the entire prostate is usually treated. By using the
ultrasound analysis, it is largely possible to avoid injury to
the surrounding tissue and other organs. During the treatment,
a computer determines the correct area to be treated in three
dimensions and marks it on the ultrasound picture. The transducer
head then emits ultrasounds with a frequency of four megahertz
(MHz). The sound waves are bundled, just like they would be in
a concave mirror, into a focal point that is about three to four
centimeters away.
The schematic drawing explains
how the high-intensity ultrasound functions: the ultrasound (blue
green) is radiated from the transducer head so that it concentrates
in the focal point and causes the desired heat effect there (red
area). The area to be irradiated with ultrasound is exactly calculated
with the help of ultrasound images and computers.
An alternative
transducer head makes it possible to go down to a depth of 2.5 or
5 centimeters. The heat developed there is between 90° to 100°
C, while the tissue through which the radiation has to travel is
almost not heated, let alone injured. The prostate or cancer tissue
is destroyed in the focal point of the ultrasound; the rest of this
coagulation is taken care of by the body itself. After each shot,
the ultrasound focal point is guided through the diseased tissue,
millimeter by millimeter, with the physician monitoring the success
of the treatment online using the ultrasound image on the computer.
With new software, which has been utilized in Heidelberg since 2007,
the transducer head can capture an even larger prostate area, reduce
the shot sequence of the pulsed ultrasounds and reduce the treatment
time overall.
Depending on the size of the prostate, the treatment takes between
two and five hours.